EpiCept Corporation (NASDAQ:EPCT) was dealt a body blow by the US Food and Drug Administration (FDA) recently with the agency rejecting the company’s new drug ...
Regency Centers Corporation (NYSE:REG), a leading operator and developer of grocery-anchored and community shopping centers across the U.S., recently purchased Glen Oak Plaza, a 62,443 square feet ret...
ImmunoGen Inc. (NASDAQ:IMGN) recently announced that the US Food and Drug Administration (FDA) granted orphan drug status to the company’s small-cell lung cancer (SCLC) candidate, lorvotuzumab merta...
“Every time I see one of these marches or forums covered as significant, what occurs to me is that there is one thing we should all be focused on instead. It is, of all things, the War on Drugs....
Regency Centers Corporation (NYSE:REG), a leading operator and developer of grocery-anchored and community shopping centers across the U.S., recently purchased Glen Oak Plaza, a 62,443 square feet ret...
Celgene Corporation (NASDAQ:CELG) could receive notification shortly regarding a patent challenge for its lead drug Revlimid (lenalidomide) 25 mg capsules. The company announced that according to a po...
Medical devices maker Integra LifeSciences Corporation (NASDAQ:IART) has reportedly initiated an urgent global recall of its NeuroBalloon Catheter. The U.S. Food and Drug Administration (FDA) is expec...
Recently, Alimera Sciences’ (ALIM) pipeline received a boost when the US Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for its lead candidate, Iluvien. Furthermore, the ...
Medical devices company Unilife Corporation (UNIS) recently obtained 510 (k) clearance from the U.S. Food & Drug Administration (FDA) for its Unitract Tuberculin (TB) Syringe, a variant of the Uni...
Recently, BioMarin Pharmaceutical Inc.’s (BMRN) pipeline received a boost with the US Food and Drug Administration (FDA) granting orphan ...